No To Five, Yes To Three: NICE Decides On Funding For Drugs In England

NICE To Review Vyndaqel Guidance Quickly If New Pricing Deal Is Reached

NICE assesses the cost effectiveness of drugs • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Health Technology Assessment

More from Market Access